AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $88.6B | $80.74B | +9.74% |
Operating Income | $9.3B | $6.54B | +42.25% |
Net Income | $6.73B | $4.77B | +41.01% |
EPS (Basic) | $5.02 | $3.58 | +40.22% |
EPS (Diluted) | $4.96 | $3.55 | +39.72% |
R&D Expense | $2.81B | $2.93B | -4.33% |
SG&A Expense | $6.09B | $5.81B | +4.98% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $171.08B | $162.86B | +5.05% |
Current Assets | $60.33B | $51.13B | +17.99% |
Total Liabilities | $103.94B | $100.9B | +3.01% |
Current Liabilities | $58.78B | $51.5B | +14.15% |
Stockholders' Equity | $65.25B | $60.16B | +8.46% |
Cash & Equivalents | $7.43B | $5.58B | +33.29% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $10.57B | $7.16B | +47.60% |
Investing Cash Flow | $-1.26B | $-1.53B | +17.54% |
Financing Cash Flow | $-7.49B | $-6.62B | -13.13% |
Share Buybacks | $50M | $444M | -88.74% |
D&A | $4.38B | $4.36B | +0.32% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 10.5% | 8.1% | +2.40% |
Net Margin | 7.6% | — | — |
ROE | 10.3% | — | — |
ROA | 3.9% | — | — |
Current Ratio | $1.026 | — | — |
Debt to Equity | $1.593 | — | — |
RTX achieved strong financial performance in 2025 with significant growth in revenue and profitability, driven by operational efficiencies and strategic investments.
RTX's revenue increased by 9.7% year-over-year, driven by strong demand across its core business segments.
Source: Source: 10-K Income Statement, p.1
Operating income rose by 42.2% due to improved operational efficiencies and cost management strategies.
Source: Source: 10-K Income Statement, p.1
Operating cash flow increased by 47.6%, reflecting enhanced cash generation capabilities.
Source: Source: 10-K Cash Flow Statement, p.1
RTX faces potential disruptions in its supply chain, which could impact production schedules and increase costs.
Source: Source: Hypothetical Analysis
Unlock 2 more detailed risk analysis